XPhyto Therapeutics Corp. (OTCMKTS:XPHYF) Sees Large Decrease in Short Interest

XPhyto Therapeutics Corp. (OTCMKTS:XPHYFGet Rating) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 3,500 shares, a decline of 20.5% from the March 31st total of 4,400 shares. Based on an average daily trading volume, of 3,500 shares, the short-interest ratio is currently 1.0 days.

Shares of XPHYF opened at $0.72 on Tuesday. The stock has a market cap of $55.99 million, a P/E ratio of -3.13 and a beta of -1.19. The company has a 50-day moving average of $0.77 and a two-hundred day moving average of $0.89. XPhyto Therapeutics has a 12-month low of $0.46 and a 12-month high of $2.14.

About XPhyto Therapeutics (Get Rating)

XPhyto Therapeutics Corp. operates as a bioscience company in Germany and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, such as depression, anxiety, addiction, and trauma-related stress disorder.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for XPhyto Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPhyto Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.